Broadwater Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Broadwater Capital's BMY Position: Q3 2026 in Review
Broadwater Capital held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 6,545 shares worth $408K. The position accounts for 0.29% of the portfolio, ranked #59.
Broadwater Capital first reported a position in BMY in Q4 2023 and has held it in 12 quarters since. The position peaked at $825K in Q1 2024. 2,533 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Broadwater Capital held 6,545 shares of Bristol-Myers Squibb worth $408K as of Q3 2026.
- Broadwater Capital left its Bristol-Myers Squibb share count unchanged in Q3 2026.
- Bristol-Myers Squibb made up 0.29% of Broadwater Capital's portfolio in Q3 2026, its #59 holding.
- Broadwater Capital first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 12 quarters since.
- Broadwater Capital's Bristol-Myers Squibb position peaked at $825K in Q1 2024.
- 2,533 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Broadwater Capital's 13F filing for Q3 2026, filed 12 Nov 2026.